The Clinical and Biological Significance of Estrogen Receptor-Low Positive Breast Cancer
Open Access
- 19 July 2023
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 36 (10) , 100284
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Higher Education and Scientific Research
This publication has 57 references indexed in Scilit:
- Preoperative core needle biopsy is accurate in determining molecular subtypes in invasive breast cancerBMC Cancer, 2013
- Effect of ASCO/CAP Guidelines for Determining ER Status on Molecular SubtypeAnnals of Surgical Oncology, 2012
- Estrogen Receptor (ER) mRNA and ER-Related Gene Expression in Breast Cancers That Are 1% to 10% ER-Positive by ImmunohistochemistryJournal of Clinical Oncology, 2012
- RNAscopeThe Journal of Molecular Diagnostics, 2012
- Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancersCancer, 2011
- Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal SubtypesClinical Cancer Research, 2009
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- Prognostic and Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors in a Randomized Trial Comparing Letrozole and Tamoxifen Adjuvant Therapy for Postmenopausal Early Breast Cancer: BIG 1-98Journal of Clinical Oncology, 2007
- The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breastJournal of Clinical Pathology, 2006
- E‐cadherin expression in invasive non‐lobular carcinoma of the breast and its prognostic significanceHistopathology, 2005